Trexquant Investment’s Amneal Pharmaceuticals AMRX Stock Holding History

Trexquant Investment’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.82M	Buy	+307,136	New	+$4.12M	0.03%	761
2025 Q3	–	Sell	-177,513	Closed	-$1.44M	–	1566
2025 Q2	$1.44M	Sell	177,513 -452,838	-72%	-$3.41M	0.02%	1003
2025 Q1	$5.28M	Buy	630,351 +167,631	+36%	+$1.4M	0.06%	483
2024 Q4	$3.66M	Buy	462,720 +223,158	+93%	+$1.87M	0.04%	637
2024 Q3	$1.99M	Buy	239,562 +180,104	+303%	+$1.41M	0.03%	813
2024 Q2	$378K	Sell	59,458 -174,750	-75%	-$1.11M	0.01%	1320
2024 Q1	$1.42M	Buy	234,208 +223,570	+2,102%	+$1.26M	0.03%	780
2023 Q4	$64.6K	Buy	+10,638	New	+$47.4K	﹤0.01%	1369

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return